Belpointe Asset Management LLC Purple Biotech Ltd. Transaction History

Belpointe Asset Management LLC

  • $1.49 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$1.38 - $2.22 $3,587 - $5,772
2,600 New
2,600 $3,000

Others Institutions Holding PPBT

# of Institutions
2
Shares Held
19.3K
Call Options Held
0
Put Options Held
0
View Full List

About PURPLE BIOTECH LTD.

PPBT Quotes by TradingView
  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $46.5M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email